Sort
48,018 grants matching “immunotherapy”
An Integrated In Vitro 3D Model of Human Bone Marrow and Peripheral Infection
$641,127Steven Carl George · University Of California At Davis · R01 · FY2021 · EB
Molecularly-based outcome and toxicity prediction after radiotherapy for lung cancer
$641,101Maximilian Diehn · Stanford University · R01 · FY2020 · CA
Human Monoclonal Antibodies for Bioterrorism Defense
$641,026Vaccinex, Inc. · R43 · FY2004 · AI
Molecular mechanisms of allele-specific NRAS signaling and tumorigenesis
$640,969Christin E Burd · Ohio State University · R01 · FY2024 · CA
The Antigen Targeting Core
$640,883Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration
$640,839Tyler J. Curiel · University Of Texas Hlth Science Center · R01 · FY2018 · CA
Multiplexed dissection of metastatic ability, organ tropism, and immune evasion
$640,760Monte Meier Winslow · Stanford University · U01 · FY2025 · CA
Small extracellular vesicles as biomarkers of prognosis and response to therapy in head and neck cancer
$640,719Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DE
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
$640,703Nicholas C Denko · Ohio State University · R01 · FY2025 · CA
Metabolic reprogramming to boost the fitness of anti-tumor immunity against metastatic colon cancer
$640,583Semir Beyaz · Cold Spring Harbor Laboratory · R37 · FY2025 · CA
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration
$640,569William Brian Reeves · University Of Texas Hlth Science Center · R01 · FY2021 · CA
Synergized Immune and Tumor Cell Bone Marrow Biomarkers to Predict Recurrence in Triple Negative Breast Cancer
$640,551Rebecca L Aft · Washington University · R01 · FY2022 · CA
Synergized Immune and Tumor Cell Bone Marrow Biomarkers to Predict Recurrence in Triple Negative Breast Cancer
$640,551Rebecca L Aft · Washington University · R01 · FY2023 · CA
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration
$640,547Tyler J. Curiel · University Of Texas Hlth Science Center · R01 · FY2020 · CA
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
$640,540Ellis L Reinherz · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Mining the microbiome for immunomodulatory microproteins
$640,522Ami Siddharth Bhatt · Stanford University · R01 · FY2025 · CA
Molecular Determinants and Therapeutic Consequences of Immune Heterogeneity in Cancer
$640,513Robert H Vonderheide · University Of Pennsylvania · R01 · FY2019 · CA
The adaptor protein Crk in immune responses
$640,503Dongfang Liu · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI
Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer
$640,450Ming You · Medical College Of Wisconsin · R01 · FY2020 · CA
Three-dimensional conformation changes associated with T cell memory and autoimmunity
$640,428Raymond David Hawkins · University Of Washington · U01 · FY2023 · DK
Uncovering the metabolic underpinnings of T cell exhaustion
$640,384Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
Uncovering the metabolic underpinnings of T cell exhaustion
$640,384Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI
Rational translation of gold nanoparticle mediated radiosensitization to the clinic
$640,366Sunil Krishnan · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · CA
CD4+ T cells and neoantigens in melanoma immunotherapy.
$640,273Rongfu Wang · University Of Southern California · R01 · FY2021 · CA
CD4+ T cells and neoantigens in melanoma immunotherapy.
$640,273Rongfu Wang · University Of Southern California · R01 · FY2025 · CA